Markets

Cytokinetics (CYTK) Looks Good: Stock Adds 6.8% in Session

Cytokinetics, IncorporatedCYTK was a big mover last session, as the company saw its shares rise almost 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $7.39-$8.41 in the past one-month time frame.

In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cytokinetics currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

CYTOKINETCS INC Price

CYTOKINETCS INC Price | CYTOKINETCS INC Quote

A better-ranked stock from the Medical-Biomedical/Gene industry is is ANI Pharmaceuticals, Inc. ANIP , which sports a Zacks Rank #1 (Strong Buy).

Is CYTK going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CYTOKINETCS INC (CYTK): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ANIP CYTK

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More